Abbas Dehghan
@Abbasdehghan
Epidemiologist, Genome Wide Association, Studies (GWAS), DNA Methylation, Metabolomics, Type 2 Diabetes and Cardiovascular diseases
ID:47680534
http://nl.linkedin.com/in/abbasdehghan 16-06-2009 17:17:46
800 Tweets
776 Followers
495 Following
Registration is open for the 6th online Mendelian randomisation course, May 23-24, 2024: imperial.ac.uk/school-public-…
James Yarmolinsky
Ville Karhunen
Verena Zuber
Kostas Tsilidis Imperial School of Public Health
Our systematic inflammatory marker & cancer MR analysis now out in eBioMedicine – The Lancet Discovery Science. Thx to
daniela Ville Karhunen Niki Dimou Dipender Gill george davey smith Abbas Dehghan Kostas Tsilidis Richard Martin & many others ICEP
Imperial School of Public Health & to Cancer Research UK for funding
twtr.to/BdQtT
We have an exciting Senior Research Associate post using #genetics to⬆️ #cancer early detection MRC IEU. Hybrid/remote working options. PhD or MSc w/ gen epi experience req'd. Closes 21 Dec Philip Haycock 🎗 Karl Smith-Byrne (he/him). Get in touch if interested! Pls retweet🙏shorturl.at/nrM79
Prof Abbas Dehghan closing out today's phenomenal UK Dementia Research Institute workshop imperial.ac.uk/a-z-research/d…. It's been a tour de force and a platform to launch new #collaborations for #Dementia research
Professor Arfan Ikram from Erasmus Medical Center, Rotterdam, NL on 'What makes dementia research so difficult? a few methodological considerations'. Joanna Tzoulaki Jennifer Podesta Imperial School of Public Health @vere
Dr James Yarmolinski, Advanced research fellow at Imperial college on 'Genetically proxied drug target perturbation for dementia research. UK Dementia Research Institute Jennifer Podesta Imperial School of Public Health Joanna Tzoulaki Verena Zuber
Dr Verena Zuber on single cell Menfelian randomisation on human brain disease and behaviour. UK Dementia Research Institute Jennifer Podesta Joanna Tzoulaki Imperial School of Public Health Verena Zuber
Professor Neil Davies from UCL on 'The causes of Alzheimers disease, Mendelian randomisation: what do we know and what next?' UK Dementia Research Institute Joanna Tzoulaki Verena Zuber Jennifer Podesta Imperial School of Public Health
Professor Sudha Seshadri from UT Health San Sntonio US on aging, resilience, multimorbidity and dementia in the older old. UK Dementia Research Institute Imperial School of Public Health Joanna Tzoulaki Verena Zuber
Professor Monique Bteteler from German Centrr for Neurodegerative disorders (DZNE) on Population research into healthy and unhealthy brain aging. UK Dementia Research Institute Joanna Tzoulaki Sam Howat
Our DRI workshop on 'Molecular epidemiology and big data in dementia research' started at Scale Space by a plenary talk by Professor Hofman from Harvard.
Joanna Tzoulaki
Verena Zuber
UK Dementia Research Institute
@imperialsph
To top off a great week of meetings in London with Abbas Dehghan, Mark Albers and other colleagues from Harvard University and MGH Neurology, we received news of our R01 NIH renewal to continue our work on drug repurposing for dementia 🎉🔝💯💪
Our 5th online Mendelian randomisation course is on May 22-23. Invited speakers Prof Burgess Stephen Burgess Prof Butterworth Adam Butterworth Dr Yarmolinsky James Yarmolinsky Dr Karhunen Ville Karhunen and Dr Sanderson. imperial.ac.uk/school-public-…
Rima Mustafa Loukas Zagkos Verena Zuber Kostas Tsilidis